Douglas Chapnick

CEO & Founder at BioLoomics

Doug’s academic career initially focused on understanding the molecular mechanisms behind signaling networks and cell behavior. He was an integral team member in the DARPA Rapid Threat Assessment project at The University of Colorado, Boulder, where he gained expertise in proteomics, metabolomics, and phenotypic microscopy screening. He has also authored over 16 academic research publications.

Location

Boulder, United States

Links


Org chart


Teams


Offices


BioLoomics

BioLoomics, Inc. is a synthetic biology company building the next generation of high-throughput drug screening tools.


Industries

Employees

1-10

Links